Related Experiment Video
Updated: Jul 13, 2026

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
Diabetic cardiomyopathy and its prevention by metallothionein: experimental evidence, possible mechanisms and
1Department of Medicine, the University of Louisville, Louisville, KY 40202, USA. L0cai001@louisville.edu
Insights
Metallothioneins (MTs) protect the heart from diabetic cardiomyopathy by acting as antioxidants and regulating zinc. Zinc supplementation may offer a clinical strategy to prevent diabetic heart complications.
Area of Science:
- Cardiology
- Biochemistry
- Endocrinology
Background:
- Diabetic cardiomyopathy is a major cause of mortality in diabetic patients, with oxidative stress being a primary driver.
- Metallothioneins (MTs) are antioxidant proteins with known protective roles in the heart.
- Understanding MT's mechanisms in diabetic hearts is crucial for developing preventative strategies.
Purpose of the Study:
- To review the role of Metallothioneins (MTs) in preventing diabetic cardiomyopathy.
- To highlight MT's antioxidant functions and mechanisms in the diabetic heart.
- To discuss the clinical implications of MT induction, particularly via zinc supplementation.
Main Methods:
- Review of existing research on MTs in diabetic cardiomyopathy.
- Analysis of experimental evidence from transgenic mice models (cardiac-specific MT-overexpressing and OVE26MT mice).
- Examination of MT's roles in calcium regulation, zinc homeostasis, insulin sensitization, and antioxidant action.
Main Results:
- MTs demonstrate significant cardiac protection against diabetes through antioxidant and other mechanisms.
- MTs play critical roles in maintaining redox homeostasis and zinc balance in the heart.
- MTs are inducible by agents like zinc, suggesting therapeutic potential.
Conclusions:
- MTs are key players in protecting the heart from diabetic damage.
- Zinc supplementation is a promising clinical approach to induce cardiac MT and prevent diabetic cardiomyopathy.
- Further research into MT's mechanisms and clinical application is warranted.
Abstract:
Cardiac failure is a leading cause for the mortality of diabetic patients, in part due to a specific cardiomyopathy, referred to as diabetic cardiomyopathy, which occurs with or without co-existence of vascular diseases. Although several mechanisms responsible for diabetic cardiomyopathy have been proposed, oxidative stress is widely considered as one of the major causes for the pathogenesis of the disease. Thus, a few laboratories are trying to develop antioxidants used to prevent diabetic cardiomyopathy. Metallothioneins (MTs) are cysteine-rich metal-binding proteins with several biological roles including antioxidant property. We and others have indicated the significant cardiac protection of MT against diabetes using cardiac-specific MT-overexpressing transgenic mice and OVE26MT mice (cross-bred of cardiac MT transgenic mice with genetically engineered diabetic OVE26 mice). Several possible mechanisms responsible for MT's cardiac protection from diabetes were revealed. These include MT's important roles in calcium regulation, zinc homeostasis, insulin sensitization, and antioxidant action. Since MT is ubiquitously expressed in mammalian tissues and is highly inducible by a variety of reagents such as zinc, the clinical potential for inducing cardiac MT as an antioxidant by zinc supplementation to prevent various diabetic complications, including cardiomyopathy, has been explored in diabetic animal models and patients. Since zinc has been therapeutically used for several other non-diabetic diseases in clinics, it provides further potential use of zinc for diabetic patients. Therefore, this review will briefly introduce the biochemical features of MT along with its critical roles in redox homeostasis and antioxidant function in the heart, and then discuss the current research on the prevention of diabetic cardiomyopathy by MT with an emphasis on experimental evidence, possible mechanisms, and clinical implications.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Type II Diabetes I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Type II Diabetes II: Pathophysiology
Myocarditis I: Introduction
